INVENTING THE FUTURE OF MEDICINE
Researchers led by UW Department of Bioengineering Professor Valerie Daggett have developed synthetic peptides that can target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease. The team reports their achievement in a paper published the week of April 15 in the Proceedings of the National Academy of Sciences.
UW Bioengineering faculty Valerie Daggett, Wendy Thomas, Rong Tian and Chun Yuan were inducted to the AIMBE College of Fellows Class of 2017. 29 BioE core and adjunct faculty are AIMBE Fellows, and this year's class is the largest inducted in the department's history.
Patrick Stayton, the Distinguished Career Professor of Bioengineering and director of the UW Molecular Engineering and Sciences Institute, and Valerie Daggett, professor of bioengineering, will present 2016-2017 UW Medicine Science in Medicine Lectures.
UW Bioengineering Professors Suzie Pun and Valerie Daggett have been elected to the AIMBE College of Fellows Class of 2015. Drs. Pun and Daggett join UW Bioengineering's 18 other AIMBE Fellows. AIMBE, or the American Institute for Medical and Biological Engineering,is a non-profit advocacy organization dedicated to improving lives through medical and biological engineering.
UW Bioengineering Professor Dr. Valerie Daggett is hosting December 2014's UW Walker Ames lecturer, Dr. Michael Levitt, the Robert W. Vivian K. Cahill Professor of Cancer Research in the Department of Structural Biology at Stanford School of Medicine. Dr. Levitt is a 2013 Nobel Laureate in Chemistry and was also Dr. Daggett's postdoc advisor in the early 1990s.
UW Bioengineering Professor Dr. Valerie Daggett's research was featured in an article, "Innovative Medicine", published in the November 2014 issue of Alaska Airlines Magazine. The article discussed novel approaches to treating complex diseases currently being developed by Seattle-area researchers, and details Dr. Daggett's work designing peptides to neutralize harmful changes to proteins thought to have a role in amyloid diseases like Alzheimer's.
UW Bioengineering Professor Dr. Valerie Daggett and research team members have designed a peptide structure that can stop harmful changes of proteins in the body that are linked to diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease (ALS).
